The clinical presentation and diagnosis of SSc lung disease, the treatment of SSc in general, and the treatment of SSc-associated pulmonary arterial hypertension are discussed separately.

Scleroderma-associated interstitial lung disease, or “SSc-ILD”, is a chronic lung disease in which scar tissue (“fibrosis”) and/or inflammation builds up in the walls of the air sacs of the lungs in a person …

May 15, 2024 · Interstitial lung disease (ILD) is a complication of systemic sclerosis that may affect breathing. Here’s a big picture overview of what this complication is, what signs to watch out for, …

Oct 7, 2025 · Interstitial lung disease associated with systemic sclerosis (SSc-ILD) is one of the important pulmonary manifestations of systemic sclerosis. It usually gives a NSIP type pattern with …

Explore information on Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD), including resources, clinical trials, congresses, support tools.

Apr 1, 2024 · Interstitial lung disease (ILD) is a common and potentially devastating complication of systemic sclerosis (SSc), a chronic autoimmune disorder charac…

Scleroderma is an autoimmune condition where the immune system mistakenly attacks its own tissues, leading to thickening and hardening of the skin and internal organs. When this process affects the …

1 day ago · Interstitial lung disease (ILD) is a poor prognostic complication of systemic sclerosis (SSc), which is life-threatening [1]. Diagnosis of SSc–ILD is challenging, requiring multidisciplinary …

Jan 14, 2020 · Through a robust modified Delphi process developed by a diverse panel of experts, the first evidence-based consensus statements were established on guidance for the identification and …

Interstitial lung disease (ILD) is a common and potentially devastating complication of systemic sclerosis (SSc), a chronic autoimmune disorder characterized by brosis and vascular abnormalities. The …